1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow EVUSHELD: new trials by email Literature Review of EVUSHELD trials Research Report on EVUSHELD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL EVUSHELD - Chronic Lymphocytic Leukemia, COVID-19 | Phase 2 | Withdrawn | Sunnybrook Health Sciences Centre | 2023-10-01 | 2024-04-04 |
COVID-19 (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1)
Sunnybrook Health Sciences Centre (1)
Canada (1)